




Instance: composition-en-24658ce59b10f683d894acb365dd27b9
InstanceOf: CompositionUvEpi
Title: "Composition for granpidam Package Leaflet"
Description:  "Composition for granpidam Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpb74880010ee00fa085fc324d80a57036)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - granpidam"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Granpidam is and what it is used for </li>
<li>What you need to know before you take Granpidam </li>
<li>How to take Granpidam </li>
<li>Possible side effects  </li>
<li>How to store Granpidam </li>
<li>Contents of the pack and other information  </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What granpidam is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What granpidam is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Granpidam contains the active substance sildenafil which belongs to a group of medicines called 
phosphodiesterase type 5 (PDE5) inhibitors. 
Granpidam brings down blood pressure in the lungs by widening the blood vessels in the lungs. 
Granpidam is used to treat adults and children and adolescents from 1 to 17 years old with high blood 
pressure in the blood vessels in the lungs (pulmonary arterial hypertension). </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take granpidam"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take granpidam"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Granpidam </p>
<ul>
<li>if you are allergic to sildenafil or any of the other ingredients of this medicine (listed in 
section 6). </li>
<li>if you are taking medicines containing nitrates, or nitric oxide donors such as amyl nitrate 
( poppers ). These medicines are often given for relief of chest pain (or  angina pectoris ). 
Granpidam can cause a serious increase in the effects of these medicines. Tell your doctor if you 
are taking any of these medicines. If you are not certain, ask your doctor or pharmacist. </li>
<li>if you are taking riociguat. This drug is used to treat pulmonary arterial hypertension (i.e., high 
blood pressure in the lungs) and chronic thromboembolic pulmonary hypertension (i.e., high 
blood pressure in the lungs secondary to blood clots). PDE5 inhibitors, such as sildenafil have 
been shown to increase the hypotensive effects of this medicine. If you are taking riociguat or 
are unsure tell your doctor. </li>
<li>if you have recently had a stroke, a heart attack or if you have severe liver disease or very low 
blood pressure (&lt;90/50 mmHg). </li>
<li>if you are taking a medicine to treat fungal infections such as ketoconazole or itraconazole or 
medicines containing ritonavir (for HIV). </li>
<li>if you have ever had loss of vision because of a problem with blood flow to the nerve in the eye 
called non-arteritic anterior ischaemic optic neuropathy (NAION). </li>
</ul>
<p>Warnings and precautions 
Talk to your doctor before taking Granpidam if you:</p>
<ul>
<li>have a disease due to a blocked or narrow vein in the lungs rather than a blocked or narrow 
artery. </li>
<li>have a severe heart problem. </li>
<li>have a problem with the pumping chambers of your heart </li>
<li>have high blood pressure in the blood vessels in the lungs. </li>
<li>have low blood pressure at rest. </li>
<li>lose a large amount of body fluids (dehydration) which can occur when you sweat a lot or do 
not drink enough liquids. This can happen if you are sick with a fever, vomiting, or diarrhoea. </li>
<li>have a rare inherited eye disease (retinitis pigmentosa). </li>
<li>have an abnormality of red blood cells (sickle cell anaemia), cancer of blood cells (leukaemia), 
cancer of bone marrow (multiple myeloma), or any disease or deformity of the penis. </li>
<li>currently have a stomach ulcer, a bleeding disorder (such as haemophilia) or problems with nose 
bleeds. </li>
<li>take medicines for erectile dysfunction. </li>
</ul>
<p>When used to treat male erectile dysfunction (ED), the following visual side effects have been 
reported with PDE5 inhibitors, including sildenafil at an unknown frequency; partial, sudden, 
temporary, or permanent decrease or loss of vision in one or both eyes. </p>
<p>If you experience sudden decrease or loss of vision, stop taking Granpidam and contact your 
doctor immediately (see also section 4). </p>
<p>Prolonged and sometimes painful erections have been reported in men after taking sildenafil. If you 
have an erection, which lasts continuously for more than 4 hours, stop taking Granpidam and 
contact your doctor immediately (see also section 4). </p>
<p>Special considerations for patients with kidney or liver problems 
You should tell your doctor if you have kidney or liver problems, as your dose may need to be 
adjusted. </p>
<p>Children 
Granpidam should not be given to children below 1 year of age. </p>
<p>Other medicines and Granpidam 
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other 
medicines. </p>
<ul>
<li>Medicines containing nitrates, or nitric oxide donors such as amyl nitrate ( poppers ). These 
medicines are often given for relief of angina pectoris or  chest pain  (see section 2. Do not take 
Granpidam) </li>
<li>Tell your doctor or pharmacist if you are already taking riociguat. </li>
<li>Therapies for pulmonary hypertension (e.g. bosentan, iloprost) </li>
<li>Medicines containing St. John s Wort (herbal medicinal product), rifampicin (used to treat 
bacterial infections), carbamazepine, phenytoin and phenobarbital (used, among others, to treat 
epilepsy) </li>
<li>Blood thinning medicines (for example warfarin) although these did not result in any side effect. </li>
<li>Medicines containing erythromycin, clarithromycin, telithromycin (these are antibiotics used to 
treat certain bacterial infections), saquinavir (for HIV) or nefazodone (for mental depression), as 
your dose may need to be adjusted. </li>
<li>Alpha-blocker therapy (e.g. doxazosin) for the treatment of high blood pressure or prostate 
problems, as the combination of the two medicines may cause symptoms resulting in the 
lowering of your blood pressure (e.g. dizziness, light headedness). </li>
<li>Medicines containing sacubitril/valsartan, used to treat heart failure. </li>
</ul>
<p>Granpidam with food and drink 
You should not drink grapefruit juice while you are being treated with Granpidam. </p>
<p>Pregnancy and breast-feeding 
If you are pregnant, or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor or pharmacist for advice before taking this medicine. Granpidam should not be used 
during pregnancy unless strictly necessary. 
Granpidam should not be given to women of child bearing potential unless using appropriate 
contraceptive methods. 
Granpidam passes into your breast milk at very low levels and would not be expected to harm your 
baby. </p>
<p>Driving and using machines 
Granpidam can cause dizziness and can affect vision. You should be aware of how you react to the 
medicine before you drive or use machines. </p>
<p>Granpidam contains lactose 
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor 
before taking this medicinal product. </p>
<p>Granpidam contains sodium 
This medicine contain less than 1 mmol sodium (23 mg) per tablet, that is to say essentially  sodium-
free . </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take granpidam"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take granpidam"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist 
if you are not sure. </p>
<p>For adults, the recommended dose is 20 mg three times a day (taken 6 to 8 hours apart) taken with or 
without food. </p>
<p>Use in children and adolescents 
For children and adolescents aged 1 year to 17 years old, the recommended dose is either 10 mg three 
times a day for children and adolescents  20 kg or 20 mg three times a day for children and 
adolescents &gt;20 kg, taken with or without food. Higher doses should not be used in children. This 
medicine should be used only in case of administration of 20 mg three times a day. Other 
pharmaceutical forms may be more appropriate for administration to patients   20 kg and other 
younger patients who are not able to swallow tablets. </p>
<p>If you take more Granpidam than you should 
You should not take more medicine than your doctor tells you to. 
If you take more medicine than you have been told to take contact your doctor immediately. Taking 
more Granpidam than you should may increase the risk of known side effects. </p>
<p>If you forget to take Granpidam 
If you forget to take Granpidam, take a dose as soon as you remember, then continue to take your 
medicine at the usual times. Do not take a double dose to make up for a forgotten dose. </p>
<p>If you stop taking Granpidam 
Suddenly stopping your treatment with Granpidam may lead to your symptoms getting worse. Do not 
stop taking Granpidam unless your doctor tells you to. Your doctor may tell you to reduce the dose 
over a few days before stopping completely. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.  </p>
<p>If you experience any of the following side effects you should stop taking Granpidam and contact a 
doctor immediately (see also section 2):</p>
<ul>
<li>if you experience sudden decrease or loss of vision (frequency not known) </li>
<li>if you have an erection, which lasts continuously for more than 4 hours. Prolonged and 
sometimes painful erections have been reported in men after taking sildenafil (frequency not 
known). </li>
</ul>
<p>Adults 
Side effects reported very commonly (may affect more than 1 in 10 people) were headache, facial 
flushing, indigestion, diarrhoea and pain in the arms or legs. </p>
<p>Side effects reported commonly (may affect up to 1 in 10 people) included: infection under the skin, 
flu-like symptoms, inflammation of the sinuses, reduced number of red blood cells (anaemia), fluid 
retention, difficulty sleeping, anxiety, migraine, shaking,  pins and needles -like sensation, burning 
sensation, reduced sense of touch, bleeding at the back of the eye, effects on vision, blurred vision and 
light sensitivity, effects on colour vision, eye irritation, bloodshot eyes /red eyes, vertigo, bronchitis, 
nosebleed, runny nose, cough, stuffy nose, stomach inflammation, gastroenteritis, heartburn, piles, 
abdominal distension, dry mouth, hair loss, redness of the skin, night sweats, muscle aches, back pain 
and increased body temperature. </p>
<p>Side effects reported uncommonly (may affect 1 in 100 people) included: reduced sharpness of vision, 
double vision, abnormal sensation in the eye, penile bleeding, presence of blood in semen and/or 
urine, and breast enlargement in men. </p>
<p>Skin rash and sudden decrease or loss of hearing and decreased blood pressure have also been reported 
at an unknown frequency (frequency cannot be estimated from the available data). </p>
<p>Children and adolescents 
The following serious adverse events have been reported commonly (may affect up to 1 in 10 people); 
pneumonia, heart failure, right heart failure, heart related shock, high blood pressure in the lungs, chest 
pain, fainting, respiratory infection, bronchitis, viral infection in the stomach and intestines, urinary 
tract infections and tooth cavities. </p>
<p>The following serious adverse events were considered to be treatment related and were reported 
uncommonly (may affect up to 1 in 100 people), allergic reaction (such as skin rash, swelling of the 
face, lips and tongue, wheezing, difficulty breathing or swallowing), convulsion, irregular heart-beat, 
hearing impairment, shortness of breath, inflammation of the digestive tract, wheezing due to 
disrupted airflow. </p>
<p>Side effects reported very commonly (may affect more than 1 in 10 people) were headache, vomiting, 
infection of the throat, fever, diarrhoea, flu and nosebleed. </p>
<p>Side effects reported commonly (may affect up to 1 in 10 people) were nausea, increased erections, 
pneumonia and runny nose. </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store granpidam"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store granpidam"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton and blister after  EXP . 
The expiry date refers to the last day of that month. </p>
<p>This medicinal product does not require any special storage conditions. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Granpidam contains 
- The active substance is sildenafil. Each tablet contains 20 mg of sildenafil (as citrate).<br />
- The other ingredients are:<br />
Tablet core: microcrystalline cellulose, calcium hydrogen phosphate, croscarmellose sodium 
(see section 2  Granpidam contains sodium ), hypromellose 2910 (E464), magnesium stearate 
Film coat: hypromellose 2910 (E464), titanium dioxide (E171), lactose monohydrate, triacetin. </p>
<p>What Granpidam looks like and contents of the pack 
White to off white, round shaped, approximately 6.6 mm in diameter, biconvex, film-coated tablets, 
debossed with  20  on one side and plain on other side. </p>
<p>Granpidam 20 mg film-coated tablets are provided in PVC/Alu blister packs containing 90 tablets and 
300 tablets. 
Granpidam 20 mg film-coated tablets are also provided in PVC/Alu perforated unit dose blister packs 
containing 15x1, 90x1 and 300x1 tablets. </p>
<p>Not all pack sizes may be marketed.  </p>
<p>Marketing Authorisation Holder 
Accord Healthcare S.L.U.<br />
World Trade Center, Moll de Barcelona, s/n,<br />
Edifici Est 6  planta,<br />
08039 Barcelona,<br />
Spain </p>
<p>Manufacturer 
Accord Healthcare B.V.,<br />
Winthontlaan 200,<br />
3526 KV Utrecht,<br />
The Netherlands<br />
or </p>
<p>Laboratori Fundaci  DAU 
C/ C, 12-14 Pol. Ind. Zona Franca, 08040 Barcelona, 
Spain </p>
<p>or </p>
<p>Accord Healthcare Polska Sp.z o.o., 
ul. Lutomierska 50,95-200 Pabianice, Poland </p>
<p>This leaflet was last revised in 07/2Detailed information on this medicine is available on the European Medicines Agency website: 
http://www.ema.europa.eu. </p>         </div>"""      



Instance: composition-da-24658ce59b10f683d894acb365dd27b9
InstanceOf: CompositionUvEpi
Title: "Composition for granpidam Package Leaflet"
Description:  "Composition for granpidam Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpb74880010ee00fa085fc324d80a57036)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - granpidam"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen 
1. Virkning og anvendelse 
2. Det skal du vide, før du begynder at tage Granpidam 
3. Sådan skal du tage Granpidam 
4. Bivirkninger 
5. Opbevaring 
6. Pakningsstørrelser og yderligere oplysninger </p>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What granpidam is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What granpidam is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Granpidam indeholder sildenafil, der hører til en gruppe af lægemidler, som kaldes fosfodiesterase-
type 5- (PDE5)-hæmmere. </p>
<p>Granpidam nedsætter blodtrykket i lungerne ved at udvide blodkarrene i lungerne. </p>
<p>Granpidam bruges til at behandle voksne, børn og unge fra 1-17 år med for højt blodtryk i blodkarrene 
i lungerne (pulmonal arteriel hypertension). </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take granpidam"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take granpidam"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Granpidam 
- hvis du er allergisk over for sildenafil eller et af de øvrige indholdsstoffer i Granpidam (angivet 
i punkt 6). 
- hvis du tager lægemidler, som indeholder nitrater eller nitrogenoxiddonorer som amylnitrit 
(“poppers”). Denne type lægemiddel gives ofte til lindring af smerter i brystet (eller “angina 
pectoris”). Granpidam kan øge disse præparaters virkning i uønsket, alvorlig grad. Fortæl det til 
din læge, hvis du tager nogle af disse præparater. Er du i tvivl, så spørg lægen eller 
apotekspersonalet. 
- hvis du tager riociguat. Dette lægemiddel bruges til at behandle pulmonal arteriel hypertension 
(højt blodtryk i lungerne) og kronisk tromboembolisk pulmonal hypertension (højt blodtryk i 
lungerne som følge af blodpropper). PDE5-hæmmere, såsom sildenafil, har vist sig at øge den 
blodtrykssænkende virkning af dette lægemiddel. Tal med din læge, hvis du tager riociguat eller 
er i tvivl. 
- hvis du for nylig har haft et slagtilfælde, eller et hjerteanfald, eller hvis du har alvorlig 
leversygdom eller meget lavt blodtryk (&lt;90/50 mmHg). 
- hvis du tager lægemidler til behandling af svampeinfektioner som f.eks. ketoconazol eller 
itraconazol eller lægemidler, som indeholder ritonavir (mod hiv). </p>
<ul>
<li>hvis du på noget tidspunkt tidligere har haft tab af synet på grund af problemer med 
blodtilførslen til nerven i øjet, tilstanden kaldes non-arteritis anterior iskæmisk opticusneuropati 
(NAION). </li>
</ul>
<p>Advarsler og forsigtighedsregler 
Kontakt lægen, før du tager Granpidam, hvis du 
- hvis du har sygdom forårsaget af blokeret eller forsnævret vene i lungerne og ikke en blokeret 
eller forsnævret arterie. 
- hvis du har et alvorligt hjerteproblem. 
- hvis du har problemer med, at hjertekamrene ikke pumper normalt. 
- hvis du har for højt blodtryk i blodkarrene i lungerne. 
- hvis du har lavt blodtryk i hvile. 
- hvis du har mistet store mængder væske (dehydrering), dette kan ske, hvis du sveder meget, 
eller hvis du ikke drikker nok væske. Det kan ske, hvis du er syg med feber, kaster op eller har 
diarré. 
- hvis du har en sjælden, arvelig øjensygdom (retinitis pigmentosa). 
- hvis du har unormale røde blodlegemer (seglcelleanæmi), blodkræft (leukæmi), 
knoglemarvskræft (myelomatose/multipelt myelom) 
- hvis du har en hvilken som helst sygdom eller deformitet af penis. 
- for tiden har mavesår eller har blødningsforstyrrelse (som f.eks. hæmofili) eller hyppigt får 
næseblod. 
- hvis du tager lægemiddel for impotens (erektil dysfunktion). </p>
<p>Når PDE5-hæmmere, herunder sildenafil, bruges til behandling af rejsningsproblemer hos mænd, er 
der med ukendt hyppighed set bivirkninger, der påvirker synet: delvist, pludseligt, midlertidigt eller 
permanent nedsat syn eller synstab på det ene eller begge øjne. </p>
<p>Hvis du oplever pludseligt nedsat syn eller synstab, skal du stoppe med at tage Granpidam og 
straks kontakte lægen (se også punkt 4). </p>
<p>Vedvarende og nogle gange smertefulde erektioner er set hos mænd efter indtagelse af sildenafil. Hvis 
du får erektion, som varer længere end 4 timer, skal du stoppe med at tage Granpidam og straks 
kontakte lægen (se også punkt 4). </p>
<p>Særlige hensyn i forbindelse med patienter med nyre- eller leverproblemer 
Fortæl lægen, hvis du har nyre- eller leverproblemer, da dosis måske skal justeres. </p>
<p>Børn 
Granpidam bør ikke gives til børn under 1 år. </p>
<p>Brug af andre lægemidler sammen med Granpidam 
Fortæl det altid til lægen eller apotekspersonalet, hvis du bruger andre lægemidler, for nylig har brugt 
andre lægemidler eller planlægger at bruge andre lægemidler. </p>
<ul>
<li>lægemidler, der indeholder nitrater eller såkaldte nitrogenoxiddonorer som f.eks. amylnitrit 
(“poppers”). Denne type lægemidler bruges ofte til lindring af angina pectoris eller 
“brystsmerter” (se punkt 2 Brug ikke Granpidam). </li>
<li>lægemidler, der indeholder riociguat. </li>
<li>behandling af pulmonal hypertension (f.eks. bosentan eller iloprost). </li>
<li>lægemidler, der indeholder perikon (naturlægemidler), rifampicin (mod tuberkulose), 
carbamazepin, phenytoin og phenobarbital (bruges bl.a. til behandling af epilepsi). </li>
<li>blodfortyndende lægemidler (f.eks. warfarin), selv om det ikke resulterede i bivirkninger. </li>
<li>
<p>lægemidler, der indeholder erythromycin, clarithromycin, telithromycin (antibiotika til at 
behandle visse typer bakterieinfektioner), saquinavir (mod hiv) eller nefazodon (mod 
depression), da dosis måske skal justeres. </p>
</li>
<li>
<p>alfa-blokker (f.eks. doxazosin) til behandling af for højt blodtryk eller vandladningsbesvær ved 
forstørret blærehalskirtel (prostata), da kombination af disse to lægemidler kan give symptomer 
på grund af blodtryksnedsættelse (f.eks. svimmelhed). </p>
</li>
<li>medicin, der indeholder sacubitril/valsartan, som bruges til behandling af hjertesvigt. </li>
</ul>
<p>Brug af Granpidam sammen med mad og drikke </p>
<p>Du må ikke drikke grapefrugtjuice, mens du er i behandling med Granpidam. </p>
<p>Graviditet og amning 
Hvis du er gravid eller ammer, har mistanke om, at du er gravid eller planlægger at blive gravid, skal 
du spørge din læge til råds, før du tager dette lægemiddel. Granpidam må kun bruges under graviditet, 
hvis det er strengt nødvendigt. 
Granpidam må ikke gives til kvinder i den fødedygtige alder, medmindre der benyttes sikker 
prævention. Granpidam udskilles i modermælken i meget små mængder og forventes ikke at skade 
barnet. </p>
<p>Trafik- og arbejdssikkerhed 
Granpidam kan give svimmelhed og kan påvirke synet. Vær opmærksom på, hvordan du reagerer på 
lægemidler, inden du fører motorkøretøj eller betjener maskiner. </p>
<p>Granpidam indeholder lactose 
Kontakt lægen, før du tager dette lægemiddel, hvis lægen har fortalt dig, at du ikke tåler visse 
sukkerarter. </p>
<p>Granpidam indeholder natrium 
Dette lægemiddel indeholder mindre end 1 mmol (23 mg) natrium pr. tablet, dvs. det er i det 
væsentlige natriumfrit. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take granpidam"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take granpidam"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag altid lægemidlet nøjagtigt efter lægens anvisning. Er du i tvivl, så spørg lægen eller 
apotekspersonalet.  </p>
<p>Til voksne er den sædvanlige dosis 20 mg 3 gange dagligt (taget med 6-8 timers mellemrum). 
Tabletten tages sammen med eller uden mad. </p>
<p>Brug til børn og unge 
Den sædvanlige dosis til børn og unge i alderen 1-17 år er 10 mg 3 gange dagligt ved legemsvægt 
20 kg eller derunder og 20 mg 3 gange dagligt ved legemsvægt over 20 kg. Granpidam kan tages 
sammen med eller uden mad. Der må ikke bruges højere doser til børn. Dette lægemiddel må kun 
bruges i de tilfælde, hvor dosis er 20 mg 3 gange dagligt. Andre lægemiddelformer kan være bedre 
egnet til patienter ved legemsvægt 20 kg eller derunder og yngre patienter som ikke kan synke 
tabletter. </p>
<p>Hvis du har taget for meget Granpidam 
Du må ikke tage mere lægemiddel, end din læge har foreskrevet. 
Kontakt straks lægen, hvis du har taget mere lægemiddel, end lægen har foreskrevet. Hvis du har taget 
mere Granpidam, end du skal, kan det øge risikoen for bivirkninger. </p>
<p>Hvis du har glemt at tage Granpidam 
Hvis du glemmer at tage Granpidam, så tag en dosis, så snart du kommer i tanke om det, og fortsæt så 
med at tage dit lægemiddel til den sædvanlige tid. Du må ikke tage en dobbeltdosis som erstatning for 
den glemte dosis. </p>
<p>Hvis Du holder op med at tage Granpidam </p>
<p>Hvis du pludseligt stopper med at tage Granpidam, kan dine symptomer blive forværret. Stop ikke 
med at tage Granpidam, medmindre det sker i samråd med lægen. Lægen vil bede dig om, at nedsætte 
dosis over nogle få dage, førend du standser behandlingen fuldstændigt. </p>
<p>Spørg lægen eller apotekspersonalet, hvis der er noget, du er i tvivl om. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som alle andre lægemidler give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Hvis du oplever en af følgende bivirkninger, skal du stoppe med at tage Granpidam og straks søge 
læge (se også punkt 2):</p>
<ul>
<li>pludseligt nedsat syn eller synstab (hyppighed er ukendt) </li>
<li>erektion, som varer uafbrudt i mere end 4 timer. Vedvarende og til tider smertefulde erektion er 
set hos mænd efter indtagelse af sildenafil (hyppighed er ukendt). </li>
</ul>
<p>Voksne </p>
<p>Meget almindelige bivirkninger (kan forkomme hos flere end 1 ud af 10 patienter) er hovedpine, 
rødmen i ansigtet, mavebesvær, diarré og smerter i arme og ben. </p>
<p>Almindelige bivirkninger (kan forkomme hos op til 1 ud af 10 patienter) er: Infektion under huden, 
influenzalignende symptomer, bihulebetændelse, nedsat antal røde blodlegemer (blodmangel), 
væskeansamling, søvnbesvær, angst, migræne, rysten, prikkende og stikkende fornemmelse, 
brændende fornemmelse, nedsat følesans, blødning bag i øjet, påvirkning af synet, sløret syn og 
lysfølsom, ændret farvesyn, øjenirritation, blodsprængte øjne/røde øjne, svimmelhed, bronkitis, 
næseblod, løbende næse, hoste, tilstoppet næse, mavekatar, maveonde, hjertebanken, hæmorroider, 
oppustet mave, mundtørhed, hårtab, rødmen af huden, svedtendens om natten, muskelsmerter, 
rygsmerter, forhøjet legemstemperatur. </p>
<p>Ikke almindelige bivirkninger (kan forkomme hos op til 1 ud af 100 patienter) omfatter: nedsat 
skarpsyn, dobbeltsyn, unormal følelse i øjet, blødning fra penis, blod i sæden og/eller urinen samt 
forstørrelse af brysterne hos mænd. </p>
<p>Hududslæt og pludselig hørenedsættelse eller døvhed og for lavt blodtryk er også set (hyppighed er 
ukendt, kan ikke vurderes ud fra tilgængelige data). </p>
<p>Børn og unge </p>
<p>Følgende alvorlige bivirkninger er almindelige (kan forkomme hos op til 1 ud af 10 patienter): 
lungebetændelse, hjertesvigt, højresidigt hjertesvigt, shock pga. hjerteproblemer, højt blodtryk i 
lungerne, smerter i brystet, besvimelse, infektion i luftvejene, bronkitis, virusinfektion i maven og 
tarmen, urinvejsinfektion og huller i tænderne. </p>
<p>Følgende alvorlige bivirkninger betragtes som forbundet med behandlingen og er ikke almindelige 
(kan forkomme hos op til 1 ud af 100 patienter): allergisk reaktion (såsom hududslæt, hævelser i 
ansigt, læber og tunge, hvæsende vejrtrækning, åndedrætsbesvær og synkebesvær), kramper, 
uregelmæssig puls, nedsat hørelse, åndenød, betændelseslignende reaktion i mave-tarmkanalen og 
hvæsende vejrtrækning pga. blokering af luftvejene. </p>
<p>Meget almindelige bivirkninger (kan forkomme hos flere end 1 ud af 10 patienter): hovedpine, 
opkastning, halsbetændelse, feber, diarré, influenza og næseblod. </p>
<p>Almindelige bivirkninger (kan forkomme hos op til 1 ud af 10 patienter): kvalme, hyppigere, 
forlænget eller kraftigere erektion, herunder spontan erektion, lungebetændelse og løbenæse. </p>
<p>Indberetning af bivirkninger 
Hvis du oplever bivirkninger, bør du tale med din læge, apotekspersonalet eller sygeplejersken. Dette 
gælder også mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. Du eller dine pårørende 
kan også indberette bivirkninger direkte til Lægemiddelstyrelsen via nationale rapporteringssystem 
anført i Appendiks V.Ved at indrapportere bivirkninger kan du hjælpe med at fremskaffe mere 
information om sikkerheden af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store granpidam"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store granpidam"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar lægemidlet utilgængeligt for børn. </p>
<p>Brug ikke lægemidlet efter den udløbsdato, der står på pakningen og blisterpakningen (efter EXP). 
Udløbsdatoen er den sidste dag i den nævnte måned. </p>
<p>Dette lægemiddel kræver ingen særlige forholdsregler vedrørende opbevaringen. </p>
<p>Spørg apotekspersonalet, hvordan du skal bortskaffe lægemiddelrester. Af hensyn til miljøet må du 
ikke smide lægemiddelrester i afløbet, toilettet eller skraldespanden. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Granpidam indeholder </p>
<ul>
<li>Aktivt stof: sildenafil. Hver tablet indeholder 20 mg sildenafil (som citrat). </li>
<li>Øvrige indholdsstoffer: 
Tabletkerne: Mikrokrystallinsk cellulose, calciumhydrogenfosfat, croscarmellosenatrium (se 
punkt 2 ”Granpidam indeholder natrium”), hypromellose 2910 (E464), magnesiumstearat. 
Filmovertræk: Hypromellose 2910 (E464), titandioxid (E171), lactosemonohydrat, triacetin. </li>
</ul>
<p>Udseende og pakningsstørrelse 
Hvide til råhvide, runde, bikonvekse, filmovertrukne tabletter med en diameter på ca. 6,6 mm, præget 
med ”20” på den ene side og glatte på den anden side. </p>
<p>Granpidam 20 mg filmovertrukne tabletter leveres i PVC/alu-blisterpakninger med 90 tabletter og 
300 tabletter. </p>
<p>Granpidam 20 mg filmovertrukne tabletter fås også i PVC/Alu perforeret enhedsdosis-blisterpakninger 
med 151, 901 og 3001 tabletter. </p>
<p>Ikke alle pakningsstørrelser er nødvendigvis markedsført. </p>
<p>Indehaver af markedsføringstilladelsen og fremstiller </p>
<p>Indehaver af markedsføringstilladelsen 
Accord Healthcare S.L.U.<br />
World Trade Center, Moll de Barcelona, s/n,<br />
Edifici Est 6ª planta,<br />
08039 Barcelona,<br />
Spanien </p>
<p>Fremstiller 
Laboratori Fundació DAU 
C/ C, 12-14 Pol. Ind. Zona Franca,  08040 Barcelona, 
Spanien </p>
<p>eller </p>
<p>Accord Healthcare Polska Sp.z o.o., 
ul. Lutomierska 50,95-200 Pabianice, Polen </p>
<p>eller </p>
<p>Accord Healthcare B.V.,<br />
Winthontlaan 200,<br />
3526 KV Utrecht,<br />
Holland </p>
<p>Denne indlægsseddel blev senest ændret </p>
<p>Du kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside http://www.ema.europa.eu. </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-24658ce59b10f683d894acb365dd27b9
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for granpidam Package Leaflet for language en"
Description: "ePI document Bundle for granpidam Package Leaflet for language en"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-24658ce59b10f683d894acb365dd27b9"
* entry[0].resource = composition-en-24658ce59b10f683d894acb365dd27b9

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp24658ce59b10f683d894acb365dd27b9"
* entry[=].resource = mp24658ce59b10f683d894acb365dd27b9
                            
                    
Instance: bundlepackageleaflet-da-24658ce59b10f683d894acb365dd27b9
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for granpidam Package Leaflet for language da"
Description: "ePI document Bundle for granpidam Package Leaflet for language da"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-24658ce59b10f683d894acb365dd27b9"
* entry[0].resource = composition-da-24658ce59b10f683d894acb365dd27b9

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp24658ce59b10f683d894acb365dd27b9"
* entry[=].resource = mp24658ce59b10f683d894acb365dd27b9
                            
                    



Instance: mp24658ce59b10f683d894acb365dd27b9
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product granpidam"
Description: "granpidam"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/16/1137/001"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"


* indication = "Adults"


* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"


* name
  * productName = "granpidam"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#DK "DK"
    * jurisdiction = urn:iso:std:iso:3166#DK "DK"
    * language = urn:ietf:bcp:47#en  "en"




RuleSet: 24658ce59b10f683d894acb365dd27b9ListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "granpidam"

* status = #current
* mode = #working

* title = "List of all ePIs associated with granpidam"

* subject = Reference(mpb74880010ee00fa085fc324d80a57036)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#granpidam "granpidam"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-24658ce59b10f683d894acb365dd27b9) // granpidam en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-24658ce59b10f683d894acb365dd27b9) // granpidam da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-24658ce59b10f683d894acb365dd27b9
InstanceOf: List

* insert 24658ce59b10f683d894acb365dd27b9ListRuleset
    